Concepedia

Author

Donna LeBherz

The University of Texas MD Anderson Cancer Center

Also Known As

D LeBherz, D. LeBherz, D. Lebherz, Donna LeBherz

9

Publications

406

Citations

6

H-Index

17

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterUniversity of Maryland, Baltimore
DL

About

Donna LeBherz is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

87

2

Pharmacology

3

3

87

3

Immunology

2

2

74

4

Gastroenterology

1

1

13

5

Pathology

1

1

36

Donna LeBherz

×

6

Publications

399

Citations

6

H-Index

YearCitations

Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors

Mansoor N. Saleh, Steve Sugarman, James H. Murray,

Journal of Clinical Oncology

2000

194

A Phase II Study of BTI-322, a Monoclonal Anti-CD2 Antibody, for Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease

Donna Przepiorka, Gordon L. Phillips, Voravit Ratanatharathorn,

Blood

1998

60

A Phase II Study of BTI-322, a Monoclonal Anti-CD2 Antibody, for Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease

Donna Przepiorka, Gordon L. Phillips, Voravit Ratanatharathorn,

Blood

1998

58

Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment.

James L. Murray, Daniel J. Macey, Edward Grant,

PubMed

1995

38

Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.

Daniel J. Macey, Edward Grant, Leela P. Kasi,

PubMed

1997

36

Anti-Gal Titers in Healthy Adults and Inflammatory Bowel Disease Patients

Andreas Mangold, Donna LeBherz, Pavol Papay,

Transplantation Proceedings

2011

13

Page 1